ERBB2 and breast cancer: Recently, the upstream target of tetrocarcin A (51) was found to be junctional adhesion molecule-A (JAM-A), a regulator of human epidermal growth factor receptor-2 (HER2) protein expression in breast cancer cells [94,95].